uminberdesigns@gmail.com+91 79840 10616Gujarat, India
Home/Industries/Healthcare & AYUSH

Healthcare & AYUSH, carefully engineered.

Deterministic screening AI you can defend, data-quality and scheme-delivery systems for public health, and pharma brand-and-web that clears the compliance bar. Health work is judged on accuracy, fairness and accountability — a tool that can't explain a decision, a scheme that leaks because the data is dirty, a brand that trips a compliance line are real risks, not rounding errors. We build careful software for a careful field. ⚕️

0–100deterministic scoring
Hard gatesdefensible screening
Phase-1MVP-first delivery
IN + UAEhealth bodies served
/ 01 — The reality

In healthcare, "roughly right" isn't good enough.

A screening tool that can't explain itself, a scheme that leaks on dirty data, a pharma brand that crosses a compliance line — each is a real risk. We build deterministic, explainable systems and brand work that respects the rules.

Screening is subjective and slow

Ideas, applications or cases are judged inconsistently by different reviewers, with no repeatable standard and no audit trail.

Scheme data is dirty

Duplicate, incomplete or mismatched records mean benefits leak, eligibility is wrong, and reporting can't be trusted.

DBT and empanelment move too slowly

Direct benefit transfers and provider empanelment stall in manual queues; turnaround time is the complaint.

AYUSH adherence is hard to track

Patients drop off treatment and there's no system-level view of who's adhering and who isn't.

Health brands walk a compliance line

Pharma marketing that's too loud invites trouble; too quiet and no one trusts the product.

/ 02 — What we build

Careful software for a field that has to be careful.

Deterministic screening, public-health data systems, document AI and compliance-aware pharma brand-and-web from one team.

Deterministic by default. Same input, same output.

We understand public-health plumbing — data quality, DBT, empanelment and adherence are the real bottlenecks, and that's what our systems target. Every AI decision shows its reasoning, the only kind that survives a clinical or audit review.

MVP-first, department-friendly. Prove value in Phase 1 on modest budgets, with infrastructure you procure — not a moon-shot you can't sign off.

Screening · Scheme data · Pharma web
SSIP / Shreya · Deterministic scoring

Screening that gives the same score every time.

Subjective, slow review is the complaint we hear most in health and biotech assessment. We replace it with a repeatable 0–100 score, hard eligibility gates and a reasoning panel that shows exactly how the number was reached — so a reviewer, an auditor and an applicant all see the same logic.

  • Deterministic 0–100 scoring — same input, same output
  • Hard gates for eligibility and safety thresholds
  • Visible reasoning that survives a clinical or audit review
See AI Systems
PMJAY · AYUSH · Scheme data

The plumbing behind a scheme that actually reaches people.

Benefits leak when the data is dirty and turnaround stalls in manual queues. Our PMJAY and AYUSH proposals target the real bottlenecks — data-quality cleanup, faster DBT, quicker empanelment turnaround and treatment-adherence tracking — each scoped as a Phase-1 MVP on a modest budget, with infrastructure the department procures.

  • Data-quality cleanup and record de-duplication
  • Faster direct benefit transfer (DBT) and empanelment TAT
  • AYUSH treatment-adherence tracking at system level
Enterprise / ERP
/ 04 — What changes

Defensible decisions, cleaner delivery.

Health software earns its place when a decision can be explained, a scheme reaches the right people, and a brand stays inside the line. That is what our systems are built to deliver.

Auditable
Every decision explained
A 0–100 score with hard gates and visible reasoning, defensible to a committee or auditor.
Consistent
Same input, same output
Deterministic scoring removes reviewer-to-reviewer drift and the "who assessed it" lottery.
Cleaner
Scheme data you can trust
De-duplicated, complete records so benefits reach the right people and reporting holds up.
Compliant
Brand inside the line
Pharma and AYUSH messaging that reads as credible without crossing a regulatory line.
/ 05 — Why teams work with us

Careful software, for a careful field.

About the studio

Deterministic by default

Same input, same output, reasoning shown — the only kind of AI that survives a clinical or audit review.

We understand public-health plumbing

Data quality, DBT, empanelment and adherence are the real bottlenecks, and that's what our proposals target.

Compliance-aware brand work

Pharma and AYUSH marketing that's credible without crossing a line — clear claims, clean design, real trust.

MVP-first, department-friendly

Prove value in Phase 1 on modest budgets, with infrastructure you procure — not a moon-shot you can't sign off.

Score. Reason. Defend.

Deterministic screening, cleaner scheme data and compliant health brands — from one team that treats accuracy as the baseline.

/ 06 — FAQ

Healthcare & AYUSH, answered.

Is AI reliable enough to screen healthcare applications?
When it's deterministic, yes. We build screening AI that gives a repeatable 0–100 score with hard gates and shows its reasoning, so the same submission always scores the same and every decision is auditable. That's how SSIP / Shreya screens healthcare and biotech ideas.
Can you help improve PMJAY or scheme data quality?
Yes. We've proposed targeted Phase-1 systems for data-quality cleanup, faster DBT, quicker empanelment turnaround and AYUSH adherence tracking. Each is scoped as an MVP to prove value first, with infrastructure procured by the department.
Do you build pharma websites that stay compliant?
Yes. We built the Honest Pharma brand and website with careful, credible messaging that clears the pharma compliance bar — trustworthy without over-claiming.
Can you structure prescriptions and medical forms with OCR?
Yes. We use document AI and OCR to turn prescriptions, forms and records into searchable, auditable structured data — the reliable base layer under any screening or reporting system.
Why start with a Phase-1 MVP?
Because it proves value on a modest budget before scale, with the infrastructure you procure. You see a working, defensible system in Phase 1 rather than committing to a moon-shot you can't sign off — then we expand from there.
Let's build

Tell us the problem. We'll scope a defensible Phase-1.

Screening, scheme data or a compliant pharma brand — start the conversation. Or explore every industry we serve, and siblings Government and Professional Services.